ADO 8.70% 2.1¢ anteotech ltd

Derek on 7.30 report, page-41

  1. 981 Posts.
    lightbulb Created with Sketch. 166


    Rapid antigen test importers say ‘frustrating’ regulatory delays are holding up kits for at-home use

    Suppliers of kits already approved for at-home use are facing month-long delays, but regulator says it is prioritising tests


    @knausc
    Thu 6 Jan 2022 03.30 AEDT

    Importers of already-approved Covid rapid tests say they are being frustrated by long regulatory delays blocking them from selling the devices for home use, further strangling supply at a time of peak demand.

    The Morrison government has faced sustained criticism over its failure to shore up supplies of Covid rapid tests ahead of the current Omicron wave, including by companies critical of the slow regulatory approval process.

    Currently, Australia’s health regulator, the Therapeutic Goods Administration, needs to separately approve the same rapid Covid test for use in two different settings: at home through self-testing, or at various points of care under the supervision of a health practitioner of staff member.



 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
-0.002(8.70%)
Mkt cap ! $52.28M
Open High Low Value Volume
2.2¢ 2.2¢ 2.1¢ $20.83K 964.6K

Buyers (Bids)

No. Vol. Price($)
4 2247357 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 164375 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.